Kelly M. Grotzinger

机构：GlaxoSmithKline (United States)

发表论文 52 篇 · 总被引 991 次 · h-index 17

代表论文

• A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment (2006 · British Journal of Dermatology · 被引 166)
• Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia (2011 · Current Medical Research and Opinion · 被引 114)
• Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer (2006 · Journal of Clinical Oncology · 被引 110)
• Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim (2015 · International Journal of Hematology · 被引 65)
• Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine (2014 · Annals of Oncology · 被引 59)
• Validation of the FACIT-fatigue subscale, selected items from FACT-thrombocytopenia, and the SF-36v2 in patients with chronic immune thrombocytopenia (2011 · Quality of Life Research · 被引 45)